GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.
Company Details
- Employees
- 52
- Founded
- -
- Address
- 150 Cambridgepark Dr, Cambridge,massachusetts 02140,united States
- Industry
- Biotechnology
- Website
- http://www.GentiBio.com
- Keywords
- Manager jobs.
- HQ
- Cambridge, Massachusetts
Gentibio Questions
Gentibio's website is http://www.GentiBio.com
Gentibio's LinkedIn profile is https://www.linkedin.com/company/gentibio
Gentibio has
52 employees.
View email and phone details for 52
employees at Gentibio.
Gentibio's industry is
Biotechnology
Gentibio's categories are Biotechnology
Gentibio's founding year is 2020
